Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,800.00    40.00 (1.06%)
Bid:
3,796.00
Ask:
3,804.00
Spread: 8.00 (0.211%)
Market Cap: £1.07b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Trading Update

5 Nov 2021 07:00

RNS Number : 4232R
4imprint Group PLC
05 November 2021
 

5 November 2021

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides an update on the Group's trading and operations.

 

The Group has made further encouraging progress against the backdrop of continuing uncertain and volatile market conditions.

 

In our Interim results, released on 11 August 2021, we noted that demand activity in June and July 2021 had made a good recovery, with order counts running at around 100% of the 2019 comparative, (the most recent 'normal' year). In the second half of the year to the end of October, weekly order totals have averaged 2% above 2019 levels despite our primary US market being impacted by the Delta variant.

 

Customer acquisition has remained strong, with new customer orders since the half year up 8% over the same period in 2019. This gives us confidence that the significant adjustments made to the marketing mix over the course of the pandemic have worked well, further strengthening our position in the market looking forward.

 

Pandemic-related global and local supply chain issues continue to cause inventory availability challenges, increased production times and product cost inflation in the second half of 2021. Our team is working to address these challenges wherever possible through sourcing alternative products for our customers from our wide range and, as our visibility improves, using price adjustments and other creative strategies to help mitigate cost pressure.

 

The Group remains in a strong financial position, with a cash balance of $41.9m at the October 2021 accounting month end after payment of the Interim dividend in September.

 

We remain very confident in the Group's strategy, business model and competitive position. The demand numbers so far in the second half of 2021 show clearly that our offering continues to resonate with our target customers.

 

Notwithstanding the ongoing market uncertainties, the Board expects that the Group's full year financial performance will be in line with expectations.

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0)20 3709 9680

E-mail hq@4imprint.co.uk

MHP Communications

Tel. + 44 (0)20 3128 8794

E-mail 4imprint@mhpc.com

 

Kevin Lyons-Tarr, Chief Executive Officer

David Seekings, Chief Financial Officer

 

Katie Hunt

Rachel Mann

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKQBQOBDDDDK
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.